SCHEMBL3766151

SCHEMBL3766151

Cc1ccc(-c2nc(S(=O)(=O)c3ccccc3)c(N3CCCCCC3)o2)cc1

nearest known ligand 0.91

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.91
TDP1 Q9NUW8 1/20 0.89
MAPT P10636 6/20 0.84
ALDH1A1 P00352 4/20 0.84
HPGD P15428 1/20 0.84
NPSR1 Q6W5P4 1/20 0.84
MEN1 O00255 2/20 0.81
KMT2A Q03164 2/20 0.81
MAPK1 P28482 1/20 0.81
THRB P10828 1/20 0.79
TSHR P16473 1/20 0.74
HSD17B10 Q99714 1/20 0.74
POLB P06746 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760191 0.88 MAPT (1.00) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL7673829 0.84 POLB (1.00) TP53TDP1MAPTALDH1A1MEN1
SCHEMBL7663455 0.81 ALDH1A1 (1.00) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL7674766 0.80 POLB (0.89) TP53TDP1MAPTALDH1A1NPSR1
SCHEMBL7669974 0.79 ALDH1A1 (0.84) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL7674392 0.79 POLB (0.84) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL7669890 0.79 ALDH1A1 (1.00) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL7669650 0.79 POLB (0.81) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL7699135 0.78 MAPT (0.81) TP53TDP1MAPTALDH1A1HPGD
SCHEMBL3756898 0.78 POLB (0.84) TP53TDP1MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305105-A1 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-02 US claimed
WO-2008061248-A2 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-05-22 WO claimed
US-8394788-B2 Phenylsulfoxyoxazole compound inhibitors of urea transporters THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-03-12 US disclosed
US-8394788-B2 Phenylsulfoxyoxazole compound inhibitors of urea transporters THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-03-12 US disclosed
US-8394788-B2 Phenylsulfoxyoxazole compound inhibitors of urea transporters THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-03-12 US disclosed
US-20100305105-A1 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-02 US disclosed
US-20100305105-A1 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-02 US disclosed
US-20100305105-A1 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-02 US disclosed
WO-2008061248-A2 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-05-22 WO disclosed
WO-2008061248-A2 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305105-A1 PHENYLSULFOXYOXAZOLE COMPOUND INHIBITORS OF UREA TRANSPORTERS SLC14A1, SLCO4C1, SLCO2B1 TP53 3827/4885TDP1 3690/4885MAPT 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.